Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(4):554–573. doi: 10.1111/j.1750-3639.2003.tb00485.x

Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult

Ursula Graumann 1, Richard Reynolds 2, Andreas J Steck 1, Nicole Schaeren‐Wiemers 1,✉
PMCID: PMC8096038  PMID: 14655760

Abstract

Multiple sclerosis is a chronic inflammatory disease of the CNS leading to focal destruction of myelin, still the earliest changes that lead to lesion formation are not known. We have studied the geneexpression pattern of 12 samples of normal appearing white matter from 10 post‐mortem MS brains. Microarray analysis revealed upregulation of genes involved in maintenance of cellular homeostasis, and in neural protective mechanisms known to be induced upon ischemic preconditioning. This is best illustrated by the upregulation of the transcription factors such as HIF‐1α and associated PI3K/Akt signalling pathways, as well as the upregulation of their target genes such as VEGF receptor 1. In addition, a general neuroprotective reaction against oxidative stress is suggested. These molecular changes might reflect an adaptation of cells to the chronic progressive pathophysiology of MS. Alternatively, they might also indicate the activation of neural protective mechanisms allowing preservation of cellular and functional properties of the CNS. Our data introduce novel concepts of the molecular pathogenesis of MS with ischemic preconditioning as a major mechanism for neuroprotection. An increased understanding of the underlying mechanisms may lead to the development of new more specific treatment to protect resident cells and thus minimize progressive oligondendrocyte and axonal loss.

Full Text

The Full Text of this article is available as a PDF (2.8 MB).

References

  • 1. Aboul‐Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H. (2003) Preferential loss of myelin‐associated glycoprotein reflects hypoxia‐like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 62:25–33. [DOI] [PubMed] [Google Scholar]
  • 2. Allen IV, McKeown SR. (1979) Ahistological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 41:81–91. [DOI] [PubMed] [Google Scholar]
  • 3. Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD. (2001) Axonal loss in normal‐appearing white matter in a patient with acute MS. Neurology 57:1248–1252. [DOI] [PubMed] [Google Scholar]
  • 4. Bolli R. (2000) The late phase of preconditioning. Circ Res 87:972–983. [DOI] [PubMed] [Google Scholar]
  • 5. Bothwell A, Yancopoulos GD, Alt FW. (1990) Methods for cloning and analysis of eukaryontic genes. Jones and Bartlett, Boston . [Google Scholar]
  • 6. Brosnan CF, Raine CS. (1996) Mechanisms of immune injury in multiple sclerosis. Brain Pathol 6:243–257. [DOI] [PubMed] [Google Scholar]
  • 7. Chen EY, Mazure NM, Cooper JA, Giaccia AJ. (2001) Hypoxia activates a platelet‐derived growth factor receptor/phosphatidylinositol 3‐kinase/Akt pathway that results in glycogen synthase kinase‐3 inactivation. Cancer Res 61:2429–2433. [PubMed] [Google Scholar]
  • 8. Chun JJ, Shatz CJ. (1989) Interstitial cells of the adult neocortical white matter are the remnant of the early generated subplate neuron population. J Comp Neurol 282:555–569. [DOI] [PubMed] [Google Scholar]
  • 9. Cullen PJ, Lockyer PJ. (2002) Integration of calcium and Ras signalling. Nat Rev Mol Cell Biol 3:339–348. [DOI] [PubMed] [Google Scholar]
  • 10. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. (1997) Akt phosphorylation of BAD couples survival signals to the cell‐intrinsic death machinery. Cell 91:231–241. [DOI] [PubMed] [Google Scholar]
  • 11. Eisen MB, Spellman PT, Brown PO, Botstein D. (1998) Cluster analysis and display of genome‐wide expression patterns. Proc Natl Acad Sci U S A 95:14863–14868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Farwell W, Simonyi A, Scott H, Zhang JP, Carruthers V, Madsen R, Johnson J, Sun GY. (1998) Effects of ischemic tolerance on mRNA levels of IP3R1, beta‐actin, and neuron‐specific enolase in hippocampal CA1 area of the gerbil brain. Neurochem Res 23:539–542. [DOI] [PubMed] [Google Scholar]
  • 13. Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, Canal N, Scotti G, Comi G. (1995) A magnetization transfer imaging study of normal‐appearing white matter in multiple sclerosis. Neurology 45:478–482. [DOI] [PubMed] [Google Scholar]
  • 14. Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS, Antel JP, Wolfson C, Arnold DL. (1998) Imaging axonal damage of normal‐appearing white matter in multiple sclerosis. Brain 121:103–113. [DOI] [PubMed] [Google Scholar]
  • 15. Gonzalez‐Zulueta M, Feldman AB, Klesse LJ, Kalb RG, Dillman JF, Parada LF, Dawson TM, Dawson VL. (2000) Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci U S A 97:436–441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Harris AL. (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47. [DOI] [PubMed] [Google Scholar]
  • 17. Hazzalin CA, Mahadevan LC. (2002) MAPK‐regulated transcription: a continuously variable gene switch Nat Rev Mol Cell Biol 3:30–40. [DOI] [PubMed] [Google Scholar]
  • 18. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M. (1995) Essential role of adenosine, adenosine A1 receptors, and ATP‐sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A 92:4666–4670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Jaffer ZM, Chernoff J. (2002) p21‐activated kinases: three more join the Pak. Int J Biochem Cell Biol 34:713–717. [DOI] [PubMed] [Google Scholar]
  • 20. Juurlink BH. (1997) Response of glial cells to ischemia: roles of reactive oxygen species and glutathione. Neurosci Biobehav Rev 21:151–166. [DOI] [PubMed] [Google Scholar]
  • 21. Karkela J, Bock E, Kaukinen S. (1993) CSF and serum brain‐specific creatine kinase isoenzyme (CK‐BB), neuronspecific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neurol Sci 116:100–109. [DOI] [PubMed] [Google Scholar]
  • 22. Lee JM, Grabb MC, Zipfel GJ, Choi DW. (2000) Brain tissue responses to ischemia. J Clin Invest 106:723–731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Lesnefsky EJ. (1994) Tissue iron overload and mechanisms of iron‐catalyzed oxidative injury. Adv Exp Med Biol 366:129–146. [DOI] [PubMed] [Google Scholar]
  • 24. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer‐Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L. (2002) Gene‐microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500–508. [DOI] [PubMed] [Google Scholar]
  • 25. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717. [DOI] [PubMed] [Google Scholar]
  • 26. Mayr B, Montminy M. (2001) Transcriptional regulation by the phosphorylation‐dependent factor CREB. Nat Rev Mol Cell Biol 2:599–609. [DOI] [PubMed] [Google Scholar]
  • 27. Merrill JE, Scolding NJ. (1999) Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol Appl Neurobiol 25:435–458. [DOI] [PubMed] [Google Scholar]
  • 28. Meyer G, Wahle P, Castaneyra‐Perdomo A, Ferres‐Torres R. (1992) Morphology of neurons in the white matter of the adult human neocortex. Exp Brain Res 88:204–212. [DOI] [PubMed] [Google Scholar]
  • 29. Mironov SL, Richter DW. (2000) Intracellular signalling pathways modulate K(ATP) channels in inspiratory brainstem neurones and their hypoxic activation: involvement of metabotropic receptors, G‐proteins and cytoskeleton. Brain Res 853:60–67. [DOI] [PubMed] [Google Scholar]
  • 30. Nandagopal K, Dawson TM, Dawson VL. (2001) Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther 297:474–478. [PubMed] [Google Scholar]
  • 31. Niizeki H, Kobayashi M, Horiuchi I, Akakura N, Chen J, Wang J, Hamada JI, Seth P, Katoh H, Watanabe H, Raz A, Hosokawa M. (2002) Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer 86:1914–1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Piret JP, Mottet D, Raes M, Michiels C. (2002) Is HIF‐1 alpha a pro‐ or an anti‐apoptotic protein Biochem Pharmacol 64:889–892. [DOI] [PubMed] [Google Scholar]
  • 33. Rubino A, Yellon DM. (2000) Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart Trends Pharmacol Sci 21:225–230. [DOI] [PubMed] [Google Scholar]
  • 34. Sagara J, Sugita Y. (2001) Characterization of cytosolic glutathione S‐transferase in cultured astrocytes. Brain Res 902:190–197. [DOI] [PubMed] [Google Scholar]
  • 35. Saransaari P, Oja SS. (1999) Characteristics of ischemia‐induced taurine release in the developing mouse hippocampus. Neuroscience 94:949–954. [DOI] [PubMed] [Google Scholar]
  • 36. Schaeren‐Wiemers N, Gerfin‐Moser A. (1993) A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin‐labelled cRNA probes. Histochemistry 100:431–440. [DOI] [PubMed] [Google Scholar]
  • 37. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G. (2001) Signal transduction of ischemic preconditioning. Cardiovasc Res 52:181–198. [DOI] [PubMed] [Google Scholar]
  • 38. Seko Y, Takahashi N, Tobe K, Kadowaki T, Yazaki Y. (1997) Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen‐activated protein kinase (MAPK), and stress‐activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 239:840–844. [DOI] [PubMed] [Google Scholar]
  • 39. Semenza GL. (2001) Hypoxia‐inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7:345–350. [DOI] [PubMed] [Google Scholar]
  • 40. Semenza GL. (2002) HIF‐1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8:S62–67. [DOI] [PubMed] [Google Scholar]
  • 41. Silver NC, Tofts PS, Symms MR, Barker G J, Thompson AJ, Miller DH. (2001) Quantitative contrast‐enhanced magnetic resonance imaging to evaluate blood‐brain barrier integrity in multiple sclerosis: a preliminary study. Mult Scler 7:75–82. [DOI] [PubMed] [Google Scholar]
  • 42. Smith KJ, Kapoor R, Felts PA. (1999) Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 9:69–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Suzuki H, Tomida A, Tsuruo T. (2001) Dephosphorylated hypoxia‐inducible factor 1 alpha as a mediator of p53‐dependent apoptosis during hypoxia. Oncogene 20:5779–5788. [DOI] [PubMed] [Google Scholar]
  • 44. Walton MR, Dragunow I. (2000) Is CREB a key to neuronal survival Trends Neurosci 23:48–53. [DOI] [PubMed] [Google Scholar]
  • 45. Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB. (2002) Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22:6401–6407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Ying W, Han SK, Miller JW, Swanson RA. (1999) Acidosis potentiates oxidative neuronal death by multiple mechanisms. J Neurochem 73:1549–1556. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES